Early Goal Directed Sedation vs. Standard Care Sedation
|
Ongoing
|
Dexmedetomidine
|
4
|
YS/003
|
King Saud Medical City (Riyadh)
|
Efficacy of Different Mouthwashes in the Reduction of Halitosis: A Randomized, Double Blind, Placebo-Controlled, Crossover Clinical Trial
|
Ongoing
|
Halita - AO ProRinse
|
4
|
PR oo39
|
College of Dentistry King Saud University
|
easypod connect: A regional, Multicentre, Observational study to evaluate Adherenceand Long Term Outcomes of Therapy in Paediatric subjects using “easypodTM” electromechanical device for growth hormone treatment
|
Ongoing
|
N/A
|
4
|
EMR200104-534
|
King Fahad University Hospital (Al-Khobar), alhabib
|
Observational Prospective STudy In Management of 1st line KRAS Wildtype mCRC with Erbitux™ (Cetuximab)- OPTIM1SE
|
Ongoing
|
Erbitux (Cetuximab)
|
4
|
EMR062202-561
|
King Fahad Medical City (Riyadh), King Abdulaziz Medical City NG (Riyadh), Prince Sultan Military Medical City (Riyadh), King Fahad Specialist Hospital (Dammam)
|
Postoperative Analgesic Effect ofDexmedetomidine as an Adjunct to Ropivacaine Administration in Wound Infiltration for Modified Radical Mastectomy- A Randomized controlled Trial
|
Ongoing
|
DEXMEDETOMIDINE
|
2
|
14-119
|
King Abdullah Medical City (Makkah)
|
AWARE-AMAC (A World-wide Antihistamine-Refractory chronic urticaria patient Evaluation in Asia pacific, Middle-east and African Countries (AWARE-AMAC): A noninterventional study to collect data on the management and clinical impacts of chronic urticaria in patients refractory to H1-antihistamine therapy
|
Ongoing
|
N/A
|
4
|
E3401
|
King Abdulaziz University Hospital (Jeddah), King Fahad Specialist Hospital (Dammam), King Faisal Specialist Hospital and Research Center (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah)
|
Non transfusion dependent Thalassemia Drug Registry
|
Ongoing
|
Exjade (Deferasirox)
|
4
|
E2422
|
King Abdulaziz University Hospital (Jeddah), King Abdulaziz Medical City NG (Jeddah), King Khalid University Hospital (Riyadh)
|
CogniPlus Study assessing Cognitive performance plus Physical activity in patients with Relapsing-Remitting MS under treatment with Betaferon®
|
Ongoing
|
Betaferon
|
4
|
16036
|
King Fahad Hospital (Madinah), Security Forces Hospital (Riyadh), Aseer Central Hospital, King Khalid University Hospital (Riyadh), Al-Noor Specialist Hospital (Makkah), King Abdul Aziz Specialist hospital (Taif), King Fahad Specialist Hospital (Dammam)
|
International Registry to assess mEdical Practice withlOngitudinal obseRvation for Treatment of Heart Failure(REPORT-HF)
|
Ongoing
|
N/A
|
4
|
2401
|
King Fahad Specialist Hospital (Dammam)
|
A Phase III randomized, double-blind, placebo-controlled study of LEE011 or placebo in combination with tamoxifen and goserelin or a non-steroidal aromatase inhibitor (NSAI) and goserelin for the treatment of premenopausal women with hormone receptor positive, HER2-negative, advanced breast cancer
|
Ongoing
|
LEE011 (Ribociclib)
|
3
|
CLEE011E2301
|
King Khalid University Hospital (Riyadh)_ King Faisal Specialist Hospital and Research Center (Riyadh)
|